Schedule 13G ownership disclosure
Xenon Pharmaceuticals Inc
Security class unavailable · CUSIP: 98420N105
Event date: 2018-07-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,048,333
- Percent of class
- 5.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001615774-18-006468
- Form type
- SC 13G
- Filer
- Vivo Opportunity, LLC
- CIK
- CIK 1728970
- Filed
- Jul 13, 2018
- Reporting period
- Jul 12, 2018
- Description
- Schedule 13G beneficial ownership